chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Post vax, the patient had a fever of 103 for 48 hours, was irritable and unconsolable for 3 days, and then sleepy for 2 days. The patient was treated with Tylenol and observation.
pt rcvd vax; pt devel 3 brown patches on the abdomen,looked like liver spots following vax; MD felt that the skin discoloration not related to vax;
Patient was administered an adult dose (0.5ml) of flu vaccine not indicated for patients under 18 years of age. No adverse affects were observed. Patient's mother was informed that no 2nd dose was required. CDC was notified.
I tested positive for pregnancy on March 17, 2021. on March 24th I got my first dose of the Pfizer vaccine for COVID.  On April 4, 2021 I had my first appointment with my OB / GYN. The doctor did an ultrasound and found that everything was fine with the baby. The baby was the right size and had a heartbeat. April 14th I got my second dose of Covid's vaccine. After an hour I started having  cramps. Around 1:15 PM I had a bleed (light red). Around 2:00 pm I was seen at the doctor's office. She did a new ultrasound. The doctor said she couldn't find a heartbeat during the ultrasound exam and that I was having a miscarriege
Information has been received from a pharmacist concerning a 77 year old hospitalized pt who was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent. The pt experienced a "cellulitis-like" reaction spreading from the injection site that started almost a week after the injection. Unspecified medical attention was sought. Additional info has been requested.
This spontaneous report as received from a pharmacist refers to a 74 years old female patient with arthritis. The patient had no drug reactions/allergies. On 20-FEB-2014 the patient was vaccinated with a 0.65ml dose of ZOSTAVAX (lot# J004268, expiry date: 12-JUL-2014) 0.65ml/once, Subcutaneous for prescriber recommended. Concomitant therapies included with hydroxychloroquine sulfate, warfarin sodium (manufacturer unknown), levothyroxine sodium (manufacturer unknown), verapamil, metoprolol, atorvastatin, MAXZIDE. On 03-MAR-2014 the patient had "blood work" completed and "whatever the blood showed, the patient's rheumatologist now wanted her to go on methotrexate". Additional information has been requested.
pt recv vax 14OCT96 & the next day exp a gen fine papular rash w/itching;tx w/DPH capsules;the rash is reported to be getting better;
Extreme fatigue, rhinorrhea, bi-lateral hearing loss that is ongoing at this time.  Visited ENT, checked for wax/fluid build up, no significant findings.  Course of Prednisone given with no improvement.
Terrible neuropathy in both feet that has not gone away. Have had bloodflow and nerve tests.  The neuropathy is definitely nerve-related.  Am taking 3600 mg of gabapentin to try to sleep.  I did not have anything before this!  Unfortunately it is not abating.
Initial information received on 24-Oct-2018 regarding an unsolicited valid non-serious case received from an other health professional. This case is linked with 2018SA298525 (same reporter). This case involves a four-years old patient of unknown gender who complaint of leg hurt a couple days after the injection with IPOL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VIRASAL; MMR; and DAPTACEL. On 16-Oct-2018 (also reported as 18-Oct-2018), the patient received a single 0.5 ml dose of suspect IPV (VERO) lot N1F931M (expiry date: 05-Jul-2019) via intramuscular route in the left thigh. On an unknown date, the patient complaint that the leg hurt, couple of days following the administration of IPV (VERO). It was also a case of actual medication error due to incorrect product storage because there was a temperature excursion of 56.3 Degrees for 2 hours and 52 minutes on Sept 29th before the vaccine was administered. No lab tests reported. Final diagnosis was limb injury. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for limb injury. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Itchy rash was noticed 1/16/21, continued to grow until 1/19/21 when noticed the redness was subsiding and the itchiness had stopped. Had been using Benadryl cream.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No medical history information was provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at an unspecified dose and frequency. On 13-Mar-2021, HEADACHE (Headache) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment medication also included rubbing alcohol.   This case was linked to US-MODERNATX, INC.-MOD-2021-075023 (Patient Link).
I tested positive for COVID-19 on 12/13/2022. I had sore throat, fatigue, body aches, sinus pressure, cough, and congestion. I contacted my doctor and was prescribed PAXLOVID. I also took TYLENOL, vitamin C, vitamin D, and zinc. I am still dealing with these symptoms currently. I also had numbness and tingling in my left arm at the injection site. It progressively got worse. I let my doctor know. I have not been able to use my arm as much as usual. I did some research, and it may have been human error. They might have stuck the needle in too far and did some nerve damage.
...ABOUT 10 DAYS AFTER INJECTION SITE SORENESS &  MILD "FLU-LIKE" SYMPTOMS, VERY SEVERE RIGHT LEG PAIN (SCIATIC NERVE DISTRIBUTION) BEGAN. I HAVE NEEDED HIGH DOSES OF TYLENOL & IBUPROFEN TO  KEEP ME FUNCTIONAL. MY INTERNIST THINKS IT IS VERY MUCH LIKE "POST-HERPETIC NEURALGIA, BUT WITH ONLY A FEW POX-LIKE SKIN ERUPTIONS IN THE SCIATIC NERVE AREA. THE PAIN CONTINUES NOW INTO THE 3RD MONTH POST SHINGRIX. PEOPLE SHOULD BE WARNED THAT THIS CAN HAPPEN...
Two days after receiving her 2nd dose of Shingrix, patient developed a pinkish/red circular rash about 2 inches below the injection site.   It feels slightly warm to the touch but is not raised.  Patient is experiencing no other symptoms.  Appears that the patient is potentially having an allergic reaction exacerbated by hot weather.  Advised tylenol, cold compresses, and benadryl, and to seek medical attention if fever develops or the rash worsens.
This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. No information was provided regarding the patient's medical history, concomitant medications or drug reactions/allergies.On an unknown date, the patient was vaccinated with her first dose of GARDASIL 9, in the gluteal region (vaccine administered at inappropriate site) intramuscular for prophylaxis (dose, lot number and expiration date were not reported). On an unspecified date, the patient's second dose of GARDASIL 9 was properly administered in the arm. The outcome of the event vaccine administered at inappropriate site was not reported.
Elevated heart rate from approximately 1pm to 5pm and again 5:45pm to 5:50pm.  As monitored by my Watch, resting heart rate earlier in the day ranged from 58 to 64 bpm.  During the times of elevation, resting heart rate increased to 87 to 93 bpm.  As of 6:25pm, resting heart rate returned to below 65 bpm and no further action taken.
At approximately 7pm  Friday (4 hours post vaccine), patient experienced pain in arm.  On the next day (Saturday),  redness noted on arm, she felt ill- fever, body aches.  Monday AM,  2.5x2.5 inch   area on arm is red and hot to touch ; remains very sore to touch.
Received second vaccine on 1/27/21 and started having sore throat, fatigue, congestion and runny nose on 2/8/21. Went to urgent care on 2/9/21.
On Wednesday on the 10th when I woke up I had a rash on both of my forearms. A couple of hours later I looked at it and it disappeared. Then I looked at my right arm where I got the shot and at the injection site, there is a like red spots in the circle (looked like chicken pox). When I woke up on Thursday when I woke up it spread from a circle to a rectangle shape and completely filled in with some little red spots. It has been itching. Yesterday I spoke with my doctor and they said to take some Benadryl and put ice on it and that is was okay to put Corizatone 10 cream on it.  My doctor said if it spread to call them back. I did not have Benadryl yesterday so I started taking it this morning. It appeared lighter in color after putting the cream on it. I got up early this morning and it disappeared and when I woke up this morning it was back again. This has been going on and off for the last couple of days I have had a slight cough and scratchy throat. For the last couple of weeks I have had a runny nose and been sneezing on and off this I think it connected to my allergies.
severe  nosebleed.   fever 100.1,   Had to go to the emergency room and they cauterized.
A consumer report has been received. The report concerns a 4 year old, Male consumer, who had been receiving Nasal FLUMIST. FLUMIST started on 22-Oct-2012. The patient experienced FEVER and IRRITABILITY which started on 24-Oct-2012 and TROUBLE SLEEPING which started on 22-Oct-2012. At the time of reporting, the event of TROUBLE SLEEPING, FEVER and IRRITABILITY was ongoing. The report was considered to be non-serious.
Dizzy: continuous Nausea: 1 day Hot flashes: continuous Chills: continuous  Body aches: continuous  Injection soreness: continuous  Tired: continuous
On the evening of 04/10/2021 (after first Pfizer COVID-19 vaccine), tinnitus in right ear flared to an excruciatingly high pitch and high volume, of which had not been experienced before. On the morning of 04/15/2021, I first began to experience dizziness as the tinnitus continued at a high level. As the day progressed I experienced hearing loss in the right ear along with "fullness" in the same ear. On this same day I experienced vertigo with a spinning room sensation which caused me to vomit. I also began to have trouble with balance. The intense vertigo subsided within two days, but for about three weeks I felt dizzy and had trouble with balance. On 04/22/2021 a hearing test confirmed sudden loss of hearing in my right ear. I was immediately placed on a 10 day regimen of prednisone steroids. Within days of starting the steroid, my tinnitus returned to its normal low level and I felt my hearing return as well. On 05/04/2021 a balance test confirmed 40% reduction of balance on right side as compared to left side, but it has been compensated for. On 05/06/2021 an MRI Intra-auditory Canal with Contrast demonstrated findings consistent with hydrops from the right ear canal. On 05/13/2021 I received my second Pfizer COVID-19 vaccine and experienced no symptoms of dizziness, balance or hearing loss, nor increased tinnitus. Chills, a slightly tender arm and fatigue were the only side effects I experienced from the second shot. On 05/20/2021 a second hearing test demonstrated returned hearing in my right ear and both ears were symmetrical.   In summation, my reaction to the first Pfizer COVID-19 vaccine started within hours of injection, with extreme tinnitus in my right ear. Then, five days later, I experienced hearing loss in my right ear for about a week before the loss was confirmed by a hearing test. My PCP started me on prednisone the day of my hearing test. The steroids preserved and restored my hearing within days and lessened my tinnitus. Also five days after the first vaccine, I experienced intense vertigo for a couple days and lingering dizziness with balance issues for about three weeks. It took me about a month to feel comfortable enough to drive. I experienced little to no adverse side effects from the second Pfizer COVID-19 vaccine.
PT has been complaining of numbness and tingling in his right arm that starts from his right wrist and goes to his right shoulder from the time that he got the first dose which was 4/7/2021
severe arm soreness; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Pregnant at the time of vaccination was unknown. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown. Patient experienced severe arm soreness after the first injection with outcome recovered on an unspecified date. It was unknown whether treatment was received or not. Event was considered non-serious. Prior to vaccination, was the patient diagnosed with COVID-19 was unknown. Since the vaccination, has the patient been tested for COVID-19 was unknown. Information on the lot/batch number has been requested.
2030 arm became quite sore/remaining symptom slight soreness at injection site; 1700 achiness in upper back and neck; 1700 achiness in upper back and neck; 1200 extreme fatigue/tiredness became more pronounced; On day of 2nd shot:1100 dizziness and slight headache; On day of 2nd shot:1100 dizziness and slight headache; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 47-years-old female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, Lot # EL3246, via an unspecified route of administration on 12Jan2021 at 08:30, at 47-years of age, at single dose for COVID-19 immunization. Historical vaccine included first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine (Lot # EL0140) in left arm on 22Dec2020 at 08:30 am; medical history included food allergy including fish, shellfish, seafood of all types and corn, gastrooesophageal reflux disease, an unspecified neoplasm malignant, Vertical Sleeve gastrectomy (VSG) and neuropathy peripheral, all from an unknown date. Concomitant medication included amlodipine, pantoprazole, cetirizine hydrochloride (ZYRTEC), zinc and magnesium. The patient was vaccinated in Hospital and she was not pregnant when she received the vaccine. On 12Jan2021, day of 2nd vaccine shot, at 11:00 the patient experienced dizziness and slight headache, at 12:00 she experienced extreme fatigue, at 17:00 she suffered from achiness in upper back and neck, at 20:30 her arm became quite sore; on 13Jan2021 all symptoms continued and tiredness became more pronounced and, on 14Jan2021, the only remaining symptoms were slight soreness at injection site and some achiness in upper back. All other symptoms had resolved. No treatment was received for the reported events. The patient has not been tested for COVID-19 after vaccination. At the time of the report the events dizziness, slight headache, extreme fatigue/tiredness became more pronounced had resolved and the events soreness at injection site and achiness in upper back were recovering.
A report has been received from a Physician concerning, subject of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. Patient received expired FLUMIST. The patient experienced RECEIVED EXPIRED FLUMIST which started during 2014. The outcome of the event of RECEIVED of RECEIVED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
had shingles three times, had it right now; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: had shingles three times, had it right now). The outcome of the shingles was not recovered/not resolved.   It was not reported if the reporter considered the shingles to be related to Shingles vaccine.     It was not reported if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 28-FEB-2023 This case was reported by a patient via interactive digital media. Follow-up would not possible as no contact details were available.
A nurse reported that a 19 month old male received an injection of Acel-Immune on 02/29/00. On 03/02/00, the patient developed an injection site reaction characterized by an area  of redness and warmth which was "a silver dollar in size". The patient was seen by the physician, who advised treatment with cool compresses. The patient recovered. This is 1 of 2 reports from this facility of injection site reactions following receipt of 2 different lots of Acel-Immune.
After injection 9-9-15, arm continually got increasingly sore until 10-12-15 I couldn't move my right arm without nerve/shock pains shooting down my arm and back of neck. Lost several hours of sleep each night. Physical therapy, electrodes, ultrasound, heat, cold still being treated biceps-tendonitis - shot went in tendon instead of muscle.
COVID-19 Vaccine EUA; rash at injection site; approximately 2.5 in., red, itchy, hot, slightly swollen; appeared 18 hours ago, which was 7 days after first dose of the covid vaccine; I experienced no symptoms/side effects at the time of the vaccine or afterwards until now, except minor soreness in left arm (injection site) the day after the vaccine.
No adverse effects; an adult patient (unspecified age) was administered a PROQUAD vaccine; This spontaneous report was received from a nurse and refers to an adult patient of unknown age and gender. There was no information concerning the patient's pertinent medical history, concomitant medication, drug reactions or allergies provided. On 09-MAY-2019, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, recombinant Human albumin (rHA), (lot # R020678, expiration date: 15-JAN-2020) (dose and route of administration were not provided) for prophylaxis. There were no adverse effects reported. The outcome of the event was unknown.
Expired vaccine given to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to patients) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.  Non-serious case.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow-up received contains no new information.; Sender's Comments: Non-serious case.
Coughs; Runny Eyes; Runny Nose; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughs), EYE DISCHARGE (Runny Eyes), RHINORRHOEA (Runny Nose) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 307K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughs), EYE DISCHARGE (Runny Eyes), RHINORRHOEA (Runny Nose) and HEADACHE (Headache). At the time of the report, COUGH (Coughs), EYE DISCHARGE (Runny Eyes), RHINORRHOEA (Runny Nose) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided. The reporter enquired whether these symptoms are related to Moderna vaccine.
She got the second shot of COVID-19 shot around 3 PM on 6/3. She had a sore arm, lower fever, and headache on the second day (6/4), which was expected. On 6/5, she complained about chest congestion in the morning. She described that it felt like running after a mile. I asked her to drink more water and get some rest. The discomfort didn't get away, so I consulted her pediatrician over the phone. Her pulse and blood pressure were normal (86/103/75). She didn't feel short of breath. And her finger oximeter result was 99.  In the afternoon, she described the discomfort as after some strenuous exercise and kept putting her hand over her heart. She felt tired and didn't have a good appetite for lunch or dinner, and only ate half meals. After dinner, around 9:30, she throws up and felt a little better.  Then she took a capsule of Motrin liquid gel of 200 mg ibuprofen and went to bed. She slept well and felt OK this morning.
From initial information received on 4/27/04 from the patient regarding an adverse event occurring in the USA, it was reported that the 45 year old female received her second dose of IMOVAX RABIES, lot number W1004-2, administered IM in the deltoid on an unspecified date. An unspecified amount of time later, the patient's arm became very sore and she was achy all over. She also developed slight redness at the injection site. She took Advil and Vioxx for two days to sleep. Reportedly the patient recovered from this experience. The reporter of this case is the same as for case 200401728.
Swollen  neck lymph node 5 days after  vaccine. Swollen lymph node still intact now. Notified my pcp and neck ultrasound has been done
Pfizer bivalent booster vaccine given when patient was due for monovalent primary series. No adverse effects on patient during administration or 15 minutes after
Awoke with incapacitating headache the day after the second dose. Headache has still persisted at the time of this report but has gone down in severity and is accompanied by a feeling of pressure in the head. Severe brain fog also started the day after second dose. Brain fog still continues but is intermittent and gets worse when other symptoms do. Profound fatigue started the day after the second dose and still continues and leaves me mostly housebound. Multiple episodes of post-exertional malaise have occurred in which symptoms are severely exacerbated after mental or physical exertion. I am now unable to exercise.
This case was reported by a physician and described the occurrence of syncope in a female patient who received BEXSERO. Co-suspect products included GARDASIL. On 19th December 2017, the patient received BEXSERO .5 ml and GARDASIL. On 20th December 2017, 1 days after receiving BEXSERO, the patient experienced syncope. On an unknown date, the outcome of the syncope was unknown. The reporter considered the syncope to be unrelated to BEXSERO. Additional details were provided as follows: The age at the vaccination was not reported. It was reported that the patient fainted the following day of vaccination. The reporter does not think the event was related to the vaccines.